Results 111 to 120 of about 12,125 (226)
Tirofiban Preserves Endothelial Junctions and Decreases Endothelin-1
It has been verified that glycoprotein IIb/IIIa inhibitor tirofiban can attenuate myocardial no-reflow. Myocardial no-reflow has been associated with alterations in endothelial junctions.
Yue-Jin YANG +6 more
core +1 more source
BACKGROUND Acute ischemic stroke is a cerebrovascular disease associated with high disability and mortality. Tirofiban, a platelet glycoprotein IIb/IIIa receptor antagonist, is used in conjunction with IV thrombolysis for bridging therapy, but its ...
Yu-Han Liu +9 more
semanticscholar +1 more source
BACKGROUND AND PURPOSE: Angioplasty and stent placement have been described as a bailout technique in individuals with failed thrombectomy. We aimed to investigate Stent retriever AssIsted Lysis (SAIL) with tirofiban before angioplasty and stent ...
M. Rodrigo-Gisbert +19 more
semanticscholar +1 more source
BACKGROUND: Tirofiban has been shown to be superior to aspirin in achieving functional independence at 3 months for acute ischemic stroke of atheromatous or microatheromatous origin.
Moussa Toudou-Daouda +9 more
semanticscholar +1 more source
Tirofiban counteracts endothelial cell apoptosis through the VEGF/VEGFR2/pAkt axis
Tirofiban is used in the treatment of patients with acute coronary syndrome submitted to percutaneous coronary intervention (PCI). We have, previously, shown that tirofiban stimulates VEGF expression and promotes proliferation of endothelial cells.
Biondi-Zoccai, Giuseppe +9 more
core +1 more source
Tirofiban provides 'platelet anesthesia' during cardiopulmonary bypass in baboons
Objective: Tirofiban (Aggrastat) is a reversible, nonpeptide inhibitor of platelet glycoprotein II/IIIa receptors. We tested the hypothesis that tirofiban preserves platelet number and function and shortens postoperative bleeding times in baboons after ...
Niewiarowski, S. +18 more
core +1 more source
Purposes: Intracranial hemorrhage (ICH) is a serious complication after endovascular treatment (EVT) for large vessel occlusive stroke. Using data from RESCUE BT, we aimed to investigate the relationship between intravenous tirofiban preceding EVT and ...
Feng Peng, MD +8 more
doaj +1 more source
Objective This article studies the safety profile and role of intra-arterial (IA) tirofiban as a rescue therapy in acute ischemic stroke (AIS) patients undergoing mechanical thrombectomy.
K. M. Athiyappan +6 more
semanticscholar +1 more source
Background First‐pass successful reperfusion (FPSR), defined as a successful/complete reperfusion achieved after a single thrombectomy pass, is predictive of favorable outcome in patients with acute ischemic stroke with large‐vessel occlusion.
Jun-Jie Yuan +27 more
semanticscholar +1 more source
OBJECT The use of endovascular therapy (EVT) has become a widespread strategy for the clinical management of acute ischemic stroke (AIS). However, the combination of arterial injection of tirofiban with EVT for AIS continues to be a subject of ...
Wei Li +5 more
semanticscholar +1 more source

